Terminology Service for NFDI4Health
All terms in SNOMED
| Label | Id | Description |
|---|---|---|
| Intramuscular hormone therapy (procedure) | 425917001 | |
| Palmoplantar keratoderma, spastic paralysis syndrome (disorder) | 785725008 | [A rare genetic punctate palmoplantar keratoderma disease with characteristics of discrete focal punctate keratoderma on the palms and soles and/or slowly progressive spastic paralysis, predominantly affecting the lower limbs. Lesional histology reveals pronounced orthokeratosis, acanthosis, papillomatosis, and regular undulation to the surface keratin. There have been no further descriptions in the literature since 1983.] |
| Product containing precisely fluocinolone acetonide 62.5 microgram/1 gram conventional release cutaneous ointment (clinical drug) | 331937001 | |
| Acidocella aminolytica (organism) | 427239008 | |
| Motility of spermatozoa (observable entity) | 102869007 | |
| Obstruction of pulmonary outflow tract (disorder) | 449120006 | |
| Entire inferior longitudinal muscle of tongue (body structure) | 244791005 | |
| Infection caused by Cotylophoron (disorder) | 66328003 | |
| Mercaptamine bitartrate (substance) | 109111003 | |
| Product containing precisely dexamethasone 700 microgram/1 each prolonged-release ocular implant (clinical drug) | 442878000 | |
| Intestinal gas (substance) | 392610001 | |
| Duodenal hemorrhage due to Dieulafoy vascular malformation of duodenum (disorder) | 1086031000119101 | |
| Prevention of unwanted pregnancy (procedure) | 710973002 | |
| Recreational watercraft user (person) | 257522005 | |
| Sparisoma rubripinne (organism) | 83289006 | |
| Francisella halioticida (organism) | 1096201000112107 | |
| Foreman-paper/board processor (occupation) | 159904006 | |
| Cytopathology procedure, forensic (procedure) | 21268002 | |
| Entire lumen of gallbladder (body structure) | 784197008 | |
| Hepatic glycogen synthase deficiency (disorder) | 725026008 | [A genetically inherited anomaly of glycogen metabolism and a form of glycogen storage disease characterized by fasting hypoglycemia. It is an extremely rare disease; about 20 cases have been reported in the literature so far. The disease appears in infancy or in early childhood. Patients present with morning fatigue and fasting hypoglycemia (without hepatomegaly) associated with hyperketonemia but without hyperalaninemia or hyperlactacidemia. After meals, major hyperglycemia associated with lactate and alanine increase and hyperlipidemia is observed. Caused by mutations in the GYS2 gene (12p12.2). Transmission is autosomal recessive., A genetically inherited anomaly of glycogen metabolism and a form of glycogen storage disease characterised by fasting hypoglycaemia. It is an extremely rare disease; about 20 cases have been reported in the literature so far. The disease appears in infancy or in early childhood. Patients present with morning fatigue and fasting hypoglycaemia (without hepatomegaly) associated with hyperketonaemia but without hyperalaninaemia or hyperlactacidaemia. After meals, major hyperglycaemia associated with lactate and alanine increase and hyperlipidaemia is observed. Caused by mutations in the GYS2 gene (12p12.2). Transmission is autosomal recessive.] |